To determine whether MBD2 is involved in the pathogenesis SLE through its influence on B cells, flow cytometry was employed to assess MBD2 expression in peripheral circulating B cell subsets of patients with SLE and HC (Figs. 1A, B and S1A). The gene discussed is MBD2; the disease is systemic lupus erythematosus.